Rad, S.K.; Yeo, K.K.L.; Li, R.; Wu, F.; Liu, S.; Nourmohammadi, S.; Murphy, W.M.; Tomita, Y.; Price, T.J.; Ingman, W.V.;
et al. Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells. Biomolecules 2025, 15, 55.
https://doi.org/10.3390/biom15010055
AMA Style
Rad SK, Yeo KKL, Li R, Wu F, Liu S, Nourmohammadi S, Murphy WM, Tomita Y, Price TJ, Ingman WV,
et al. Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells. Biomolecules. 2025; 15(1):55.
https://doi.org/10.3390/biom15010055
Chicago/Turabian Style
Rad, Sima Kianpour, Kenny K. L. Yeo, Runhao Li, Fangmeinuo Wu, Saifei Liu, Saeed Nourmohammadi, William M. Murphy, Yoko Tomita, Timothy J. Price, Wendy V. Ingman,
and et al. 2025. "Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells" Biomolecules 15, no. 1: 55.
https://doi.org/10.3390/biom15010055
APA Style
Rad, S. K., Yeo, K. K. L., Li, R., Wu, F., Liu, S., Nourmohammadi, S., Murphy, W. M., Tomita, Y., Price, T. J., Ingman, W. V., Townsend, A. R., & Smith, E.
(2025). Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells. Biomolecules, 15(1), 55.
https://doi.org/10.3390/biom15010055
